/

Other

/

Dicerna Pharmaceuticals Inc

Dicerna Pharmaceuticals Inc

Dicerna Pharmaceuticals Inc

Verified Nov 2026

Other

·

United States flag

Lexington, Massachusetts

·

Since 2007

Dicerna Pharmaceuticals develops RNA interference-based therapeutics targeting liver and genetic diseases. Headquartered in Lexington, Massachusetts and founded in 2007, the company operates with 50–100 employees and estimated revenue of $100–250 million. Dicerna became a wholly owned subsidiary of Novo Nordisk A/S in December 2021 following a $3.3 billion acquisition. In January 2025, Roche partnered with Dicerna on a hepatitis B gene-silencing drug program.

Dicerna Pharmaceuticals Inc

Verified Nov 2026

AT A GLANCE

Founded

2007

Headquarters

United States flag

Lexington, Massachusetts

Employees

50-100

Ownership

Dicerna Pharmaceuticals Inc at a glance

Revenue

$100-250M

Est. band

Employees

50-100

Founded

2007

Headquarters

Lexington, Massachusetts

Industries

Automotive

Electric Vehicles

Medical

Overview

Dicerna Pharmaceuticals develops RNA interference-based therapeutics targeting liver and genetic diseases. Headquartered in Lexington, Massachusetts and founded in 2007, the company operates with 50–100 employees and estimated revenue of $100–250 million. Dicerna became a wholly owned subsidiary of Novo Nordisk A/S in December 2021 following a $3.3 billion acquisition. In January 2025, Roche partnered with Dicerna on a hepatitis B gene-silencing drug program.

At a glance

Attribute

Detail

Founded

2007

Headquarters

Lexington, Massachusetts

Employees

50-100

Revenue

$100-250M (estimated)

What Dicerna Pharmaceuticals Inc makes

Dicerna utilizes its proprietary GalXC™ platform and expanded GalXC-Plus™ platform to develop RNAi-based pharmaceuticals that silence disease-causing genes, with applications in primary hyperoxaluria, chronic hepatitis B, and alcohol use disorder.

Latest developments

Facilities

Dicerna Pharmaceuticals Inc is headquartered in Lexington, Massachusetts. Public sources also reference these locations:

Company details

The company maintains active pharmaceutical partnerships, including a 2025 collaboration with Roche on hepatitis B therapeutics. Dicerna Pharmaceuticals Inc was founded in 2007, has an estimated 50-100 employees, and is headquartered in Lexington, Massachusetts.

Frequently asked questions

What does Dicerna Pharmaceuticals Inc do?

Dicerna Pharmaceuticals develops RNA interference-based therapeutics targeting liver and genetic diseases. Headquartered in Lexington, Massachusetts and founded in 2007, the company operates with 50–100 employees and estimated revenue of $100–250 million. Dicerna became a wholly owned subsidiary of Novo Nordisk A/S in December 2021 following a $3.3 billion acquisition. In January 2025, Roche partnered with Dicerna on a hepatitis B gene-silencing drug program.

Where is Dicerna Pharmaceuticals Inc headquartered?

Dicerna Pharmaceuticals Inc is headquartered in Lexington, Massachusetts.

When was Dicerna Pharmaceuticals Inc founded?

Dicerna Pharmaceuticals Inc was founded in 2007.

How big is Dicerna Pharmaceuticals Inc?

Dicerna Pharmaceuticals Inc has an estimated 50-100 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Lexington, Massachusetts (HQ)Headquarters · Massachusetts, United States
Lexington, Massachusetts (HQ)Lexington, Massachusetts, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.